Immunizations

A study has examined the availability of negative vaccine information online.

The 20vPnC pneumococcal conjugate vaccine candidate was found comparable to licensed products in safety and immunogenicity.

A new study demonstrates that the introduction of a universal immunization program had positive impact on the educational attainment of people in India’s school system.

A study has identified geographic and socioeconomic drivers of conscientious vaccine exemption choice in Texas.

The US Food and Drug Administration approved the first adjuvanted quadrivalent influenza vaccine for adults 65 years and older.

The Advisory Committee on Immunization Practices has announced changes to the 2020 child and adolescent vaccine schedule.

There could be viable options within a few months, but will it be in time to contain an outbreak?

The US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices has released the 2020 Recommended Immunization Schedule for adults.

The CDC’s Advisory Committee on Immunization Practices have updated vaccine recommendations to allow interchangeable use of Tdap and Td in some cases.

A new study provides evidence that there was no change in herd immunity among more than 34,000 students in Australia with moderate to high vaccination rates.

Despite children’s higher risk of complications from influenza, few US child care centers report influenza vaccine requirements for children and/or adult care workers.

Incorporating a signaling protein known as B cell activating factor into the rabies vaccine improved speed and strength of the antibody responses, investigators at Thomas Jefferson University found.

Asthma patients benefited from flu vaccines, according to a study that examined 6 influenza virus seasons.

While most influenza vaccines target the binding protein hemagglutinin, a new study shows cross-strain results for treatment and prevention focused on the glycoprotein neuraminidase.

An analysis of vaccination data among children born in 2015 and 2016 found high and stable coverage, but highlighted sociodemographic disparities in coverage.

Kindergarten vaccination coverage is near the recommended 95%, but nonexempt holdouts, which could be addressed, can still lead to outbreaks.

Millions of women and infants remain vulnerable to influenza and pertussis despite recommendations for vaccinations in pregnancy, according to a CDC report.

The Closing Plenary of IDWeek 2019 discussed the challenges of vaccination and the optimism that we may be on the path to eradicating some global infectious diseases.

The approval marks the first FDA-approved, non-replicating smallpox vaccine, and the only FDA-approved vaccine for prevention of monkeypox.

Touring production called “Eureka Day” depicts parents of schoolchildren arguing both sides—but definitely has a point of view.

Being geographically close a measles outbreak could change the way individuals feel about getting vaccinated against the disease.

The crux of new information centers around the vaccine virus composition for the 2019-2020 season, and recent labeling changes for previously licensed vaccines.

Texas could be the site of the next large measles outbreak in the United States, according to a new study that highlights the low vaccination rates among schools there.

Parents seeking medical exclusions for their children must now have their physician fill out a state form explaining specifically why the exemption is warranted.

Investigators in the first human trial of a MERS-CoV candidate report strong immune responses and no serious adverse events, advancing the vaccine candidate to phase 1/2a and phase 2 trials.

An update for clinical providers.

The latest guidance on preparing for and responding to measles in your health care facility.

When speaking with patients or parents, it is important for health care practitioners to stress that vaccines are safe, and vaccines save lives.

Several states have or are considering laws that would circumvent consent from anti-vax parents.

ACIP voted 10-to-4 to expand the recommended HPV vaccine “catch-up” age for men from 21 to 26, matching the existing guidelines for women.